The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems

Aim. To study quality of life (QoL) and hypoglycaemic symptoms in patients with type 2 diabetes receiving intensive insulin therapy.Materials and methods. One thousand patients with type 2 diabetes receiving intensive insulin therapy for at least 6 months were enrolled in this multicenter observatio...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tat'yana Ivanovna Ionova, Vitaliy Ivanovich Odin, Tat'yana Pavlovna Nikitina, Kira Aleksandrovna Kurbatova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2015
Materias:	patient-centered approach type 2 diabetes mellitus basal-bolus insulin therapy quality of life hypoglycemia symptoms of hypoglycemia fear of hypoglycemia Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/adcad6fef0184673a9088334c64505b0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:adcad6fef0184673a9088334c64505b0
record_format	dspace
spelling	oai:doaj.org-article:adcad6fef0184673a9088334c64505b02021-11-14T09:00:19ZThe value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems2072-03512072-037810.14341/DM6806https://doaj.org/article/adcad6fef0184673a9088334c64505b02015-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6806https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. To study quality of life (QoL) and hypoglycaemic symptoms in patients with type 2 diabetes receiving intensive insulin therapy.Materials and methods. One thousand patients with type 2 diabetes receiving intensive insulin therapy for at least 6 months were enrolled in this multicenter observational study. The mean age of patients was 61.1 years (range, 29–84 years) and the male/female ratio was 265/735. All patients completed the SF-36® questionnaire and the Comprehensive Symptom Profile-Diabetes Mellitus Hypoglycemia Module. For group comparisons, we used unpaired t-tests or Mann–Whitney tests and general linear models. To compare categorical variables, the χ2 test and Fisher’s exact test were used.Results. The patients with type 2 diabetes receiving intensive insulin therapy demonstrated heterogeneity in terms of QoL. More than half of the patients had mild QoL impartment while nearly one third experienced significant QoL impairment. The following factors had the most pronounced negative impact on QoL: late diabetic complications, concomitant diseases, poor glycemic control and type of hypoglycaemia. QoL parameters were lower in patients with hypoglycaemic episodes than in those without (p <0.01), but in patients with mild hypoglycaemia it was similar to those without. The most pronounced disturbances in QoL occurred in patients with severe and nocturnal hypoglycaemia (p <0.05). The hypoglycaemic symptoms with the greatest burden on QoL were dizziness, morning weakness, eye problems, nightmares or crying out during sleep, distress, loss of energy and sleep disturbances. Correlation between the severity of fear of hypoglycaemia and QoL was also demonstrated. Higher the fear of hypoglycaemia, the more impaired was social functioning, mental health, vitality and general health.Conclusion. Assessment of QoL and hypoglycaemic symptoms in patients with type 2 diabetes receiving intensive insulin therapy reveals the need for a patient-centred approach in treatment and for a comprehensive evaluation of treatment outcomes.Tat'yana Ivanovna IonovaVitaliy Ivanovich OdinTat'yana Pavlovna NikitinaKira Aleksandrovna KurbatovaEndocrinology Research Centrearticlepatient-centered approachtype 2 diabetes mellitusbasal-bolus insulin therapyquality of lifehypoglycemiasymptoms of hypoglycemiafear of hypoglycemiaNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 18, Iss 4, Pp 48-58 (2015)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	patient-centered approach type 2 diabetes mellitus basal-bolus insulin therapy quality of life hypoglycemia symptoms of hypoglycemia fear of hypoglycemia Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	patient-centered approach type 2 diabetes mellitus basal-bolus insulin therapy quality of life hypoglycemia symptoms of hypoglycemia fear of hypoglycemia Nutritional diseases. Deficiency diseases RC620-627 Tat'yana Ivanovna Ionova Vitaliy Ivanovich Odin Tat'yana Pavlovna Nikitina Kira Aleksandrovna Kurbatova The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems
description	Aim. To study quality of life (QoL) and hypoglycaemic symptoms in patients with type 2 diabetes receiving intensive insulin therapy.Materials and methods. One thousand patients with type 2 diabetes receiving intensive insulin therapy for at least 6 months were enrolled in this multicenter observational study. The mean age of patients was 61.1 years (range, 29–84 years) and the male/female ratio was 265/735. All patients completed the SF-36® questionnaire and the Comprehensive Symptom Profile-Diabetes Mellitus Hypoglycemia Module. For group comparisons, we used unpaired t-tests or Mann–Whitney tests and general linear models. To compare categorical variables, the χ2 test and Fisher’s exact test were used.Results. The patients with type 2 diabetes receiving intensive insulin therapy demonstrated heterogeneity in terms of QoL. More than half of the patients had mild QoL impartment while nearly one third experienced significant QoL impairment. The following factors had the most pronounced negative impact on QoL: late diabetic complications, concomitant diseases, poor glycemic control and type of hypoglycaemia. QoL parameters were lower in patients with hypoglycaemic episodes than in those without (p <0.01), but in patients with mild hypoglycaemia it was similar to those without. The most pronounced disturbances in QoL occurred in patients with severe and nocturnal hypoglycaemia (p <0.05). The hypoglycaemic symptoms with the greatest burden on QoL were dizziness, morning weakness, eye problems, nightmares or crying out during sleep, distress, loss of energy and sleep disturbances. Correlation between the severity of fear of hypoglycaemia and QoL was also demonstrated. Higher the fear of hypoglycaemia, the more impaired was social functioning, mental health, vitality and general health.Conclusion. Assessment of QoL and hypoglycaemic symptoms in patients with type 2 diabetes receiving intensive insulin therapy reveals the need for a patient-centred approach in treatment and for a comprehensive evaluation of treatment outcomes.
format	article
author	Tat'yana Ivanovna Ionova Vitaliy Ivanovich Odin Tat'yana Pavlovna Nikitina Kira Aleksandrovna Kurbatova
author_facet	Tat'yana Ivanovna Ionova Vitaliy Ivanovich Odin Tat'yana Pavlovna Nikitina Kira Aleksandrovna Kurbatova
author_sort	Tat'yana Ivanovna Ionova
title	The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems
title_short	The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems
title_full	The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems
title_fullStr	The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems
title_full_unstemmed	The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems
title_sort	value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems
publisher	Endocrinology Research Centre
publishDate	2015
url	https://doaj.org/article/adcad6fef0184673a9088334c64505b0
work_keys_str_mv	AT tatyanaivanovnaionova thevalueofpatientreportedoutcomesinpatientswithtype2diabetesmellitusreceivinginsulintherapyassessmentofqualityoflifeandhypoglycemiaproblems AT vitaliyivanovichodin thevalueofpatientreportedoutcomesinpatientswithtype2diabetesmellitusreceivinginsulintherapyassessmentofqualityoflifeandhypoglycemiaproblems AT tatyanapavlovnanikitina thevalueofpatientreportedoutcomesinpatientswithtype2diabetesmellitusreceivinginsulintherapyassessmentofqualityoflifeandhypoglycemiaproblems AT kiraaleksandrovnakurbatova thevalueofpatientreportedoutcomesinpatientswithtype2diabetesmellitusreceivinginsulintherapyassessmentofqualityoflifeandhypoglycemiaproblems AT tatyanaivanovnaionova valueofpatientreportedoutcomesinpatientswithtype2diabetesmellitusreceivinginsulintherapyassessmentofqualityoflifeandhypoglycemiaproblems AT vitaliyivanovichodin valueofpatientreportedoutcomesinpatientswithtype2diabetesmellitusreceivinginsulintherapyassessmentofqualityoflifeandhypoglycemiaproblems AT tatyanapavlovnanikitina valueofpatientreportedoutcomesinpatientswithtype2diabetesmellitusreceivinginsulintherapyassessmentofqualityoflifeandhypoglycemiaproblems AT kiraaleksandrovnakurbatova valueofpatientreportedoutcomesinpatientswithtype2diabetesmellitusreceivinginsulintherapyassessmentofqualityoflifeandhypoglycemiaproblems
_version_	1718429549866254336

The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems

Ejemplares similares